Ushbu ish iqtibos qilgan ishlar

215 ta ish

Ish: Angiogenesis and prostate cancer: MicroRNAs comes into view

Sarlavhasiz
Boshqa3 iqtibos
ABI
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Dos D. Sarbassov, Siraj M. Ali, Do‐Hyung Kim +5
Maqola20042 iqtibos
ABI
Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer
Pedro C. Barata, Matthew M. Cooney, Prateek Mendiratta +3
Maqola20182 iqtibos
ABI
Inhibition of transforming growth factor beta/<scp>SMAD</scp> signal by MiR‐155 is involved in arsenic trioxide‐induced anti‐angiogenesis in prostate cancer
Hui Ji, Yuan Li, Fei Jiang +4
Maqola20142 iqtibos
ABI
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz +10
Maqola20132 iqtibos
ABI
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami, Jianjiong Gao, Uğur Doğrusöz +12
Maqola20122 iqtibos
ABI
The Contribution of Angiogenesis to the Process of Metastasis
Diane R. Bielenberg, Bruce R. Zetter
Sharh maqola20152 iqtibos
ABI
Multiple angiogenesis stimulators in a single malignancy: Implications for anti-angiogenic tumour therapy
Helena Pavlaković, W. Havers, Lothar Schweigerer
Maqola20012 iqtibos
ABI
MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence
Malathi Ramalinga, Arpita Roy, Anvesha Srivastava +5
Maqola20152 iqtibos
ABI
Intricacies of Bevacizumab-Induced Toxicities and Their Management
Sarah M Gressett, Sachin Shah
Sharh maqola20092 iqtibos
ABI
Molecular Pathogenesis and Progression of Prostate Cancer
Randy S. Schrecengost, Karen E. Knudsen
Sharh maqola20132 iqtibos
ABI
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet, Rakesh K. Jain
Sharh maqola20112 iqtibos
ABI
MicroRNA-Based Therapeutics for Cancer
Vivien Wang, Wei Wu
Sharh maqola20092 iqtibos
ABI
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini, Maria Chiara De Santis, Laura Braccini +2
Sharh maqola20142 iqtibos
ABI
The Role of PTEN in Tumor Angiogenesis
Stéphane Rodriguez, Uyen Huynh‐Do
Maqola20112 iqtibos
ABI
Growing roles for the mTOR pathway
Dos D. Sarbassov, Siraj M. Ali, David M. Sabatini
Sharh maqola20052 iqtibos
ABI
MiR‐130b suppresses prostate cancer metastasis through down‐regulation of MMP2
Qin Chen, Xian Zhao, Hailong Zhang +8
Maqola20142 iqtibos
ABI
Forty-Year Journey of Angiogenesis Translational Research
Yihai Cao, Jack L. Arbiser, Robert J. D’Amato +9
Sharh maqola20112 iqtibos
ABI
The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review.
Noor Riza Perdana, Chaidir Arif Mochtar, H. Rainy Umbas +1
Maqola20162 iqtibos
ABI
Hostile takeover: how tumours hijack pre‐existing vascular environments to thrive
Frank Winkler
Maqola20172 iqtibos
ABI
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk, Nick Pavlakis, Steven Kao +14
Maqola20172 iqtibos
ABI
Reciprocal regulations between miRNAs and HIF-1α in human cancers
Wanli Yang, Jiaojiao Ma, Wei Zhou +6
Sharh maqola20182 iqtibos
ABI
Targeting Angiogenesis in Prostate Cancer
Zsombor Melegh, Sebastian Oltean
Sharh maqola20192 iqtibos
ABI
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
Carlo Cattrini, Elena Castro, R. Lozano Mejorada +4
Sharh maqola20192 iqtibos
ABI
Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway
Santosh Kumar Singh, Tejumola Apata, Jennifer Gordetsky +1
Maqola20192 iqtibos
ABI